Elenagen™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown significant promise in alleviating chronic pain ...

Study in Frontiers in Veterinary Science finds investigational plasmid Elenagen cut osteoarthritis pain by 50 % in dogs and ...

BOSTON: Elenagen ™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown ...

Mariam albatoul Reslan “Genes are a powerful tool for unlocking the mysteries of human health and disease.” To begin with, ...

Researchers identified SDR42E1 as a key regulator of vitamin D absorption and sterol metabolism in colorectal cancer cells.

As part of Charles River’s Cell & Gene Therapy Accelerator Program, Elly’s Team manufactured critical starting materials for ...

Abstract Summary Pharmacological enhancement of endoplasmic reticulum (ER) proteostasis is an attractive strategy to mitigate pathology linked to etiologically-diverse protein misfolding diseases.

Retroviral vector sequence maps commonly show the vector incorporated into a plasmid including full LTRs as cloned.